Stay updated on BGB-A317 Clinical Trial: Safety, PK, Antitumor Activities

Sign up to get notified when there's something new on the BGB-A317 Clinical Trial: Safety, PK, Antitumor Activities page.
Latest website image capture
Clouds background image

Latest updates to the BGB-A317 Clinical Trial: Safety, PK, Antitumor Activities page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    No meaningful content or layout changes were detected between the two screenshots; the page presents the same study details for NCT02407990.
    Difference
    0.4%
    Check dated 2025-11-03T01:30:23.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    42 days ago
    Change Detected
    Summary
    Key updates: version bump to v3.2.0 and an important government-operating-status notice; the previous v3.1.0 reference was removed. Overall, user-facing status and versioning information were updated. If no other content changed, this is a targeted update to status and versioning.
    Difference
    2%
    Check dated 2025-10-05T10:24:21.000Z thumbnail image
  5. Check
    49 days ago
    Change Detected
    Summary
    Page revision updated from v3.0.2 to v3.1.0, indicating a version bump with no other substantive content changes.
    Difference
    0.0%
    Check dated 2025-09-28T03:21:36.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    Revision updated from v3.0.1 to v3.0.2; the 'Back to Top' element was removed.
    Difference
    0.1%
    Check dated 2025-09-13T17:43:37.000Z thumbnail image
  7. Check
    71 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.
    Difference
    0.1%
    Check dated 2025-09-06T15:27:04.000Z thumbnail image
  8. Check
    78 days ago
    Change Detected
    Summary
    The web page has been updated to include specific drug information for Tislelizumab and has revised location details, including the addition of South Korea and Taiwan locations. The revision number has also been updated to v3.0.0.
    Difference
    5%
    Check dated 2025-08-30T12:16:07.000Z thumbnail image

Stay in the know with updates to BGB-A317 Clinical Trial: Safety, PK, Antitumor Activities

Enter your email address, and we'll notify you when there's something new on the BGB-A317 Clinical Trial: Safety, PK, Antitumor Activities page.